Coralmyn: Difference between revisions
Content deleted Content added
Animal bites are venomous, not poisonous. |
Added out of date. Tags: Mobile edit Mobile web edit |
||
| Line 1: | Line 1: | ||
{{outofdate}} |
|||
'''Coralmyn''', also called '''Polyvalent Anti-coral Fabotherapic''', is a [[Polyclonal B cell response|polyclonal]] [[antivenom]] F(ab')<sup>2</sup> used to treat venomous bites in mammals from the [[eastern coral snake]] and the [[Texas coral snake]]. It was manufactured in Mexico by the ''[[Instituto Bioclon]]'', and was only obtainable in the United States with an application of an USDA importer's permit and state license. Because of the relative rarity of such bites, the remaining United States reserve of this medicine has been restricted to human-only use and is set to expire in 2017. Treatment of small animals (dogs and cats) with this product following accidental bites had proven highly effective in preventing shock and death.<ref name="SilversteinHopper2014">{{cite book|author1=Deborah Silverstein|author2=Kate Hopper|title=Small Animal Critical Care Medicine|url=https://books.google.com/books?id=Cx4ZBAAAQBAJ&pg=PA916|date=5 September 2014|publisher=Elsevier Health Sciences|isbn=978-0-323-24352-0|page=916}}</ref> |
'''Coralmyn''', also called '''Polyvalent Anti-coral Fabotherapic''', is a [[Polyclonal B cell response|polyclonal]] [[antivenom]] F(ab')<sup>2</sup> used to treat venomous bites in mammals from the [[eastern coral snake]] and the [[Texas coral snake]]. It was manufactured in Mexico by the ''[[Instituto Bioclon]]'', and was only obtainable in the United States with an application of an USDA importer's permit and state license. Because of the relative rarity of such bites, the remaining United States reserve of this medicine has been restricted to human-only use and is set to expire in 2017. Treatment of small animals (dogs and cats) with this product following accidental bites had proven highly effective in preventing shock and death.<ref name="SilversteinHopper2014">{{cite book|author1=Deborah Silverstein|author2=Kate Hopper|title=Small Animal Critical Care Medicine|url=https://books.google.com/books?id=Cx4ZBAAAQBAJ&pg=PA916|date=5 September 2014|publisher=Elsevier Health Sciences|isbn=978-0-323-24352-0|page=916}}</ref> |
||
Revision as of 01:40, 1 March 2019
 | This article needs to be updated. |
Coralmyn, also called Polyvalent Anti-coral Fabotherapic, is a polyclonal antivenom F(ab')2 used to treat venomous bites in mammals from the eastern coral snake and the Texas coral snake. It was manufactured in Mexico by the Instituto Bioclon, and was only obtainable in the United States with an application of an USDA importer's permit and state license. Because of the relative rarity of such bites, the remaining United States reserve of this medicine has been restricted to human-only use and is set to expire in 2017. Treatment of small animals (dogs and cats) with this product following accidental bites had proven highly effective in preventing shock and death.[1]
References
- ^ Deborah Silverstein; Kate Hopper (5 September 2014). Small Animal Critical Care Medicine. Elsevier Health Sciences. p. 916. ISBN 978-0-323-24352-0.